Continuous carbachol infusion promotes peripheral cell proliferation and mimics vagus hyperactivity in a rat model of hypothalamic obesity

Biomedical Research

Volumn 27, Issue 2, 2006, Pages 81-88

  Yoshimura, Ryoichi ^a   Omori, Hiroshi ^a   Somekawa, Shingo ^a   Osaka, Toshimasa ^b   Ito, Rokuro ^c   Inoue, Shuji ^d   Endo, Yasuhisa ^a  

^a KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d KYORITSU WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CARBACHOL; CYCLINE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; NONHUMAN; OBESITY; OSMOTIC MINIPUMP; PANCREAS CELL; PANCREAS ISLET BETA CELL; RAT; VAGOTOMY; VAGUS NERVE STIMULATION; ZONA INCERTA;

ANIMALIA;

EID: 33646761338     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.27.81     Document Type: Article

References (53)

1. Anokhin PK and Shuleikina KV (1977) System organization of alimentary behavior in the newborn and the developing cat. Dev Psychobiol 10, 385-419.
2. Berthoud HR and Jeanrenaud B (1979) Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats. Endocrinology 105, 146-151.
3. Blundell JE and Hill AJ (1987) Serotoninergic modulation of the pattern of eating and the profile of hunger-satiety in humans. Int J Obes 3, 141-155.
4. Campfield LA, Smith FJ, Guisez Y, Devos R and Burn P (1995) Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 475-476.
5. Chen Y, Hu C, Hsu CK, Zhang Q, Bi C, Asnicar M, Hsiung HM, Fox N, Slieker LJ, Yang DD, Heiman ML and Shi Y (2002) Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 143, 2469-2477.
6. Costa L, Guizzetti M, Oberdoerster J, Yagle K, Costa-Mallen P, Tita B, Bordi F, Vitalone A, Palmery M and Valeri P (2001) Modulation of DNA synthesis by muscarinic cholinergic receptors. Growth Factors 18, 227-236.
7. Cox JE and Powley TL (1981) Intragastric pair feeding fails to prevent VMH obesity or hyperinsulinemia. Am J Physiol 240, E566-E572.
8. Cox JE and Powley TL (1981) Prior vagotomy blocks VMH obesity in pair-fed rats. Am J Physiol 240, E573-E583.
9. De Ambrogi M, Volpe S and Tamanini C (2003) Ghrelin: central and peripheral effects of a novel peptydil hormone. Med Sci Monit 9, RA217-RA224.
10. de Groot J (1959) The rat forebrain in stereotaxic coordinates. Verh K Ned Acta Wet Natuurkund 52, 1-40.
11. Della ZO, Presse F, Ortola C, Duhault J, Nahon JL and Levens N (2002) Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats. Int J Obes Relat Metab Disord 26, 1289-1295.
12. Dor Y, Brown J, Martinez OI and Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41-46.
13. Funahashi T, Shimomura I, Hiraoka H, Arai T, Takahashi M, Nakamura T, Nozaki S, Yamashita S, Takemura K, Tokunaga K and Matsuzawa Y (1995) Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem Biophys Res Commun 211, 469-475.
14. Gehlert D (1999) Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides 33, 329-338.
15. Gomori A, Ishihara A, Ito M, Mashiko S, Matsushita H, Yumoto M, Ito M, Tanaka T, Tokita S, Moriya M, Iwaasa H and Kanatani A (2003) Chronic intracerebroventricular infusion of MCH causes obesity in mice. Melanin-concentrating hormone. Am J Physiol Endocrinol Metab 284, E583-E588.
16. Gutkind J, Novotny E, Brann M and Robbins K (1991) Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci USA 88, 4703-4707.
17. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
18. Hales C and Kennedy G (1964) Plasma glucose, non-esterified fatty acid and insulin concentrations in hypothalamic-hyperphagic rats. Biochem J 90, 620-624.
19. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M and Sakurai T (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345-354.
20. Harrold JA, Widdowson PS and Williams G (1999) Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: futher evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes 48, 267-271.
21. Howard AD, Wang R, Pong SS, Mellin TN, Strack A, Guan XM, Zeng Z, Williams DJ, Feighner SD, Nunes CN, Murphy B, Stair JN, Yu H, Jiang Q, Clements MK, Tan CP, McKee KK, Hreniuk DL, McDonald TP, Lynch KR, Evans JF, Austin CP, Caskey CT, Van, der, Ploeg, Lh and Liu Q (2000) Identification of receptors for neuromedin U and its role in feeding. Nature 406, 70-74.
22. Hustvedt BE, Lovo A and Reichl D (1976) The effect of ventromedial hypothalamic lesions on metabolism and insulin secretion in rats on a controlled feeding regimen. Nutr Metab 20, 264-271.
23. Inoue S and Bray GA (1977) The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. Endocrinology 100, 108-114.
24. Inoue S, Campfield LA and Bray GA (1977) Comparison of metabolic alterations in hypothalamic and high fat diet-induced obesity. Am J Physiol 233, R162-R168.
25. Inoue S, Mullen YS and Bray GA (1983) Hyperinsulinemia in rats with hypothalamic obesity: effects of autonomic drugs and glucose. Am J Physiol 245, R372-R378.
26. Kageyama H, Kageyama A, Endo Y, Osaka T, Nemoto K, Hirano T, Namba Y, Shioda S and Inoue S (2003) Ventromedial hypothalamus lesions induce jejunal epithelial cell hyperplasia through an increase in gene expression of cyclooxygenase. Int J Obes Relat Metab Disord 27, 1006-1013.
27. Kernie SG, Liebl DJ and Parada LF (2000) BDNF regulates eating behavior and locomotor activity in mice. Embo J 19, 1290-1300.
28. Kiba T, Tanaka K, Endo O and Inoue S (1992) Role of vagus nerve in increased DNA synthesis after hypothalamic ventromedial lesions in rat liver. Am J Physiol 262, G483-G487.
29. Kiba T, Tanaka K, Endo O and Inoue S (1993) Ventromedial hypothalamic lesions increase gastrointestinal DNA synthesis through vagus nerve in rats. Gastroenterology 104, 475-484.
30. Kiba T, Tanaka K, Hoshino M, Numata K and Inoue S (1993) Comparison of DNA synthesis in white and brown adipose tissue in rats with ventromedial hypothalamic lesions. Pflugers Arch 424, 122-128.
31. Kiba T, Tanaka K, Hoshino M, Numata K, Okano K and Inoue S (1995) Ventromedial hypothalamic lesions induce the proliferation of gastrointestinal mucosal cells in the rat. Life Sci 57, 827-832.
32. Kiba T, Tanaka Y, Inoue S, Endo O and Takamura Y (1991) Comparison of DNA contents of visceral organs in rats with ventromedial hypothalamic lesions and fed a high fat diet. Neurosci Lett 126, 127-130.
33. Kiba T, Tanaka K, Numata K, Hoshino M, Misugi K and Inoue S (1996) Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation. Gastroenterology 110, 885-893.
34. Kiba T, Tanaka K, Numata K, Saito S and Sekihara H (1998) Hepatocyte proliferation in rats after ventromedial hypothalamic lesions: Immunoreactivity patterns of proliferating cell nuclear antigen (PCNA). J Gastroenterol 33, 523-528.
35. Kitabchi AE (1977) Proinsulin and C-peptide: a review. Metabolism 26, 547-587.
36. Ludwig DS, Tritos NA, Mastaitis JW, Kulkarni R, Kokkotou E, Elmquist J, Lowell B, Flier JS and Maratos FE (2001) Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 107, 379-386.
37. Maga G and Hubscher U (2003) Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 116, 3051-3060.
38. Marks HE and Davison C (1976) Hyperinsulinemia: effects on body weight, obesity and motivated behaviors. Tit J Life Sci 6, 1-10.
39. Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbauer ME, Chen AS, Guan XM, Jiang MM, Feng Y, Camacho RE, Shen Z, Frazier EG, Yu H, Metzger JM, Kuca SJ, Shearman LP, Gopal TS, MacNeil DJ, Strack AM, MacIntyre DE, Van der Ploeg LH and Qian S (2002) Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA 99, 3240-3245.
40. Nonogaki K (1999) Obesity: autonomic circuits versus feeding. Nat Med 5, 742-743.
41. Parkinson WL and Weingarten HP (1990) Dissociative analysis of ventromedial hypothalamic obesity syndrome. Am J Physiol 259, R829-R835.
42. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T and Collins F (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543.
43. Rahmouni K and Haynes W (2001) Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins. Bioessays 23, 1095-1099.
44. Richard D (1993) Involvement of corticotropin-releasing factor in the control of food intake and energy expenditure. Ann N Y Acad Sci 697, 155-172.
45. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM and Jaenisch R (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15, 1748-1757.
46. Rohner JF, Walker CD, Greco PR and Jeanrenaud B (1989) Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 124, 733-739.
47. Rothwell NJ (1990) Central effects of CRF on metabolism and energy balance. Neurosci Biobehav Rev 14, 263-271.
48. Roush W (1995) "Fat hormone" poses hefty problem for journal embargo. Science 269, 627.
49. Snowdon C and Epstein A (1970) Oral and intragastric feeding in vagotomized rats. J Comp Physiol Psychol 71, 59-67.
50. Van der Zee E, Buwalda B, Strubbe JH, Strosberg AD and Luiten PG (1992) Immunocytochemical localization of muscarinic acetylcholine receptors in the rat endocrine pancreas. Cell Tissue Res 269, 99-106.
51. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA and Bloom SR (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540-2547.
52. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH and Reichardt LF (2003) Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6, 736-742.
53. Yoshimatsu H, Niijima A, Oomura Y, Yamabe K and Katafuchi T (1984) Effects of hypothalamic lesion on pancreatic nerve activity in the rat. Brain Res 303, 147-152.